Nuveen
FLGT icon

Nuveen’s Fulgent Genetics FLGT Stock Holding History

Nuveen’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
66,725
-37,324
-36% -$633K ﹤0.01% 2776
2026
Q1 		$1.65M Sell
104,049
-227,594
-69% -$4.94M ﹤0.01% 2343
2025
Q4 		$8.71M Buy
331,643
+40,790
+14% +$1.06M ﹤0.01% 1637
2025
Q3 		$6.57M Sell
290,853
-17,848
-6% -$368K ﹤0.01% 1774
2025
Q2 		$6.14M Buy
308,701
+252,371
+448% +$4.92M ﹤0.01% 1779
2025
Q1 		$952K Hold
56,330
– – ﹤0.01% 2658
2024
Q4 		$1.04M Sell
56,330
-12,735
-18% -$249K ﹤0.01% 2697
2024
Q3 		$1.5M Sell
69,065
-5,507
-7% -$123K ﹤0.01% 2565
2024
Q2 		$1.46M Sell
74,572
-171,478
-70% -$3.58M ﹤0.01% 2534
2024
Q1 		$5.34M Sell
246,050
-29,757
-11% -$739K ﹤0.01% 1962
2023
Q4 		$7.97M Buy
275,807
+9,526
+4% +$255K ﹤0.01% 1732
2023
Q3 		$7.12M Sell
266,281
-147,176
-36% -$5.02M ﹤0.01% 1680
2023
Q2 		$15.3M Buy
413,457
+187,404
+83% +$6.53M 0.01% 1251
2023
Q1 		$7.06M Buy
226,053
+109,509
+94% +$3.52M ﹤0.01% 1693
2022
Q4 		$3.47M Buy
116,544
+23,937
+26% +$857K ﹤0.01% 2120
2022
Q3 		$3.53M Sell
92,607
-133,345
-59% -$6.68M ﹤0.01% 2100
2022
Q2 		$12.3M Buy
225,952
+130,924
+138% +$7.2M ﹤0.01% 1380
2022
Q1 		$5.98M Buy
95,028
+7,377
+8% +$486K ﹤0.01% 1969
2021
Q4 		$8.82M Sell
87,651
-4,659
-5% -$409K ﹤0.01% 1774
2021
Q3 		$8.3M Sell
92,310
-15,093
-14% -$1.37M ﹤0.01% 1906
2021
Q2 		$9.91M Buy
107,403
+49,848
+87% +$3.98M ﹤0.01% 1877
2021
Q1 		$5.56M Buy
57,555
+7,501
+15% +$774K ﹤0.01% 2122
2020
Q4 		$2.61M Buy
50,054
+17,915
+56% +$749K ﹤0.01% 2374
2020
Q3 		$1.29M Buy
32,139
+3,357
+12% +$105K ﹤0.01% 2575
2020
Q2 		$461K Buy
+28,782
New +$441K ﹤0.01% 2934

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen's FLGT Position: Q2 2026 in Review

Nuveen reduced its Fulgent Genetics (FLGT) stake by 36% in Q2 2026, selling an estimated $633K and leaving 66,725 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

Nuveen first reported a position in FLGT in Q2 2020 and has held it in 25 quarters since. The position peaked at $15.3M in Q2 2023. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Nuveen held 66,725 shares of Fulgent Genetics worth $1.37M as of Q2 2026.
  • Nuveen sold 37,324 Fulgent Genetics shares in Q2 2026, an estimated $633K.
  • Fulgent Genetics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2776 holding.
  • Nuveen first reported a position in Fulgent Genetics in Q2 2020 and has held it in 25 quarters since.
  • Nuveen's Fulgent Genetics position peaked at $15.3M in Q2 2023.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.